Bcrp breast cancer
Breast cancer resistance protein (BCRP)/ATP-binding cassette subfamily G member 2 (ABCG2) is an ATP-binding cassette (ABC) transporter identified as a . Int J Biochem Cell Biol. Apr;37(4) Breast cancer resistance protein ( BCRP/ABCG2). Staud F(1), Pavek P. Author information: (1)Department of. 3 days ago The BCRP challenges the scientific community to design research that will address the urgency of ending breast cancer. Specifically, the BCRP. The human breast cancer resistance protein (BCRP/ABCG2) is the second member of the G subfamily of the large ATP-binding cassette (ABC) transporter superfamily. BCRP was initially discovered in multidrug resistant breast cancer cell lines where it confers resistance to chemotherapeutic agents such as mitoxantrone, topotecan and methotrexate by Cited by: Since cloning of the ATP-binding cassette (ABC) family member breast cancer resistance protein (BCRP/ABCG2) and its characterization as a multidrug resistance efflux transporter in , BCRP has been the subject of more than two thousand scholarly gifporno.info by: Department of Defense – FY19 Breast Cancer Research Program (BCRP) February 6, by [email protected]
The Department of Defense (DoD) has announced its FY19 Breast Cancer Research Program (BCRP) being managed by the office of Congressionally .